AMR Policy Accelerator Publishes Rapid Scoping Review on The Effects of the COVID-19 Pandemic on the Three Core Drivers of AMR

Our AMR Policy Accelerator team conducted a rapid scoping review to explore how several factors have impacted the emergence, transmission and burden of Antimicrobial Resistance (AMR) during the COVID-19 pandemic. The living evidence synthesis looked at: antimicrobial use (AMU), infection prevention and health system changes. This living evidence synthesis was commissioned by Health Canada and Public Health Agency of Canada and was funded by Covid-End.

While more research is needed to fully understand the impact, initial findings show:

  • AMR trends varied across countries In many countries

  • AMU increased in hospitals but decreased in the community likely due to COVID countermeasures that reduced the spread of infections

Key areas were identified for further discussion & research:

  • improving AMR surveillance

  • identifying and addressing the potential inequitable effects of AMR

  • addressing gaps in the global evidence base

Read the full report here:


January 12, 2023

Dr. Susan Rogers Van Katwyk Speaks to CTV on the Impact of Antimicrobial Resistance


February 8, 2023

GSL Study featured in York University's Impact Report 2021-22: Special Issue on Research & Teaching